U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 11 - 11 of 11 results

LIPPIA ALBA WHOLE

MORE DETAILS

76HT054LK1

structurally diverse
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(2017)
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5c4230af-280e-2b73-e053-2991aa0aa4a9
First approved in 2017
Source:
21 CFR 352
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5c4230af-280e-2b73-e053-2991aa0aa4a9
Class:
STRUCTURALLY DIVERSE

Showing 11 - 11 of 11 results

NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966